Clinical Trials
11
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- Conditions
- Aortic RegurgitationAortic Valve InsufficiencyAortic Insufficiency
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2025-08-20
- Lead Sponsor
- JenaValve Technology, Inc.
- Target Recruit Count
- 1016
- Registration Number
- NCT06608823
- Locations
- 🇺🇸
BayCare Health, Clearwater, Florida, United States
🇺🇸Emory University Hospital, Atlanta, Georgia, United States
🇺🇸Houston Methodist Research Institute, Houston, Texas, United States
The JenaValve ALIGN-AR LVAD Registry
- Conditions
- Aortic RegurgitationAortic Valve InsufficiencyAortic InsufficiencyAortic Valve DiseaseLeft Ventricular Dysfunction
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- JenaValve Technology, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06594705
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Advocate Christ Medical Center, Oak Lawn, Illinois, United States
🇺🇸Henry Ford Hospital, Detroit, Michigan, United States
TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease
- Conditions
- Constriction, PathologicVentricular Outflow ObstructionHeart Valve DiseasesAortic Valve StenosisAortic Valve RegurgitationAortic Valve DiseaseAortic Stenosis, SevereAortic Valve Stenosis With InsufficiencyCardiovascular Diseases in Old Age
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- JenaValve Technology, Inc.
- Target Recruit Count
- 600
- Registration Number
- NCT05536310
- Locations
- 🇩🇪
Herz-und Diabeteszentrum NRW Ruhr-Universität Bochum Bad Oeynhausen, Bad Oeynhausen, Germany
🇩🇪University Hospital of Cologne Heart Center, Köln, Germany
🇩🇪University Hospital Mainz, Mainz, Germany
The JenaValve ALIGN-AR Pivotal Trial
- Conditions
- Aortic Valve InsufficiencyAortic InsufficiencyAortic Valve DiseaseAortic Regurgitation
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- JenaValve Technology, Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT04415047
- Locations
- 🇺🇸
TMC HealthCare & PIMA Heart, Tucson, Arizona, United States
🇺🇸Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸Scripps Hospital, San Diego, California, United States
First in Man Study of the JenaValve TAVI Plus System Transfemoral
- Conditions
- Heart DiseasesHeart Valve DiseasesAortic Valve StenosisCardiovascular Diseases
- First Posted Date
- 2016-06-30
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- JenaValve Technology, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT02818959
- Locations
- 🇩🇪
University of Hamburg Medical Center, Hamburg, Germany
🇩🇪University of Koln Medical Center, Koln, Germany
- Prev
- 1
- 2
- Next